GC
ANIK icon

Globeflex Capital’s Anika Therapeutics ANIK Stock Holding History

Globeflex Capital’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.27M Hold
87,600
– – 0.19% 128
2025
Q4 		$842K Hold
87,600
– – 0.13% 173
2025
Q3 		$823K Hold
87,600
– – 0.13% 197
2025
Q2 		$927K Hold
87,600
– – 0.08% 190
2025
Q1 		$1.32M Hold
87,600
– – 0.12% 143
2024
Q4 		$1.44M Sell
87,600
-10,399
-11% -$205K 0.12% 145
2024
Q3 		$2.42M Hold
97,999
– – 0.23% 100
2024
Q2 		$2.48M Buy
97,999
+65,864
+205% +$1.71M 0.26% 88
2024
Q1 		$816K Sell
32,135
-3,365
-9% -$81.4K 0.08% 208
2023
Q4 		$804K Buy
+35,500
New +$735K 0.08% 219
2015
Q2 		– Sell
-23
Closed -$1K – 507
2015
Q1 		$1K Sell
23
-9
-28% -$364 ﹤0.01% 416
2014
Q4 		$1K Sell
32
-5
-14% -$195 ﹤0.01% 419
2014
Q3 		$1K Sell
37
-36
-49% -$1.56K ﹤0.01% 437
2014
Q2 		$3K Sell
73
-47
-39% -$2.09K ﹤0.01% 416
2014
Q1 		$4K Sell
120
-41
-25% -$1.52K ﹤0.01% 379
2013
Q4 		$6K Hold
161
– – ﹤0.01% 373
2013
Q3 		$3K Sell
161
-11,481
-99% -$258K ﹤0.01% 392
2013
Q2 		$197K Buy
+11,642
New +$168K 0.03% 369

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Globeflex Capital's ANIK Position: Q1 2026 in Review

Globeflex Capital held its Anika Therapeutics (ANIK) position steady in Q1 2026 at 87,600 shares worth $1.27M. The position accounts for 0.19% of the portfolio, ranked #128.

Globeflex Capital first reported a position in ANIK in Q2 2013 and has held it in 18 quarters since. The position peaked at $2.48M in Q2 2024. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Globeflex Capital held 87,600 shares of Anika Therapeutics worth $1.27M as of Q1 2026.
  • Globeflex Capital left its Anika Therapeutics share count unchanged in Q1 2026.
  • Anika Therapeutics made up 0.19% of Globeflex Capital's portfolio in Q1 2026, its #128 holding.
  • Globeflex Capital first reported a position in Anika Therapeutics in Q2 2013 and has held it in 18 quarters since.
  • Globeflex Capital's Anika Therapeutics position peaked at $2.48M in Q2 2024.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Globeflex Capital's 13F filing for Q1 2026, filed 13 May 2026.